ArticleCell communication and signaling : CCS2026

A bispecific-aptamer TSHR-CD80-1 treats thyroid eye disease by inhibiting CD8

Jiamin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.